Oritavancin diphosphate
Product Specifications
CAS Number
192564-14-0
Target
Antibiotic|||Antibacterial
Related Pathways
Microbiology/Virology
Purity
>99.99%
Bioactivity
Oritavancin diphosphate (LY333328 diphosphate) is a novel semisynthetic glycopeptide antibiotic developed for treating serious Gram-positive bacterial infections.
Smiles
O[C@@H]1[C@@H](O[C@@H]2O[C@@H](C)[C@H](O)[C@@](C2)(C)NCc2ccc(c3ccc(Cl)cc3)cc2)[C@@H](O[C@H](CO)[C@H]1O)Oc1c2Oc3ccc([C@H]([C@@H](NC(=O)[C@H](NC)CC(C)C)C(=O)N[C@H](C(=O)N[C@@H]4c(c2)cc1Oc1ccc([C@H]([C@H]2C(=O)N[C@H](C(=O)O)c5c(c6cc([C@@H](NC4=O)C(=O)N2)ccc6O)c(O)cc(O)c5)O[C@@H]2O[C@@H](C)[C@H](O)[C@](C2)(N)C)cc1Cl)CC(=O)N)O)cc3Cl.O=P(O)(O)O.O=P(O)(O)O
Molecular Formula
C86H103Cl3N10O34P2
Molecular Weight
1989.09
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
129090 50 µg
LILRA3 (ILT6, CD85e, Leukocyte Immunoglobulin-like Receptor Subfamily A Member 3, CD85 Antigen-like Family Member E, Immunoglobulin-like Transcript 6, ILT-6, Leukocyte Immunoglobulin-like Receptor 4, LIR-4, Monocyte Inhibitory Receptor HM43/HM31, LIR4)
Ask
View Details